NovoCure (NVCR) Revenue Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.52% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.14% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.92% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.43% |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | 12.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.52% |
| Dec 31, 2025 | 10.73% |
| Sep 30, 2025 | 8.47% |
| Jun 30, 2025 | 4.08% |
| Mar 31, 2025 | 4.06% |
| Dec 31, 2024 | 6.58% |
| Sep 30, 2024 | 5.10% |
| Jun 30, 2024 | 4.04% |
| Mar 31, 2024 | 0.93% |
| Dec 31, 2023 | -2.41% |
| Sep 30, 2023 | -1.36% |
| Jun 30, 2023 | 2.83% |
| Mar 31, 2023 | 6.26% |
| Dec 31, 2022 | 8.98% |
| Sep 30, 2022 | 12.48% |
| Jun 30, 2022 | 17.55% |
| Mar 31, 2022 | 23.34% |
| Dec 31, 2021 | 24.12% |
| Sep 30, 2021 | 27.31% |
| Jun 30, 2021 | 29.48% |
| Mar 31, 2021 | 37.23% |
| Dec 31, 2020 | 38.95% |
| Sep 30, 2020 | 38.34% |
| Jun 30, 2020 | 44.56% |
| Mar 31, 2020 | 42.92% |
| Dec 31, 2019 | 48.60% |
| Sep 30, 2019 | 61.95% |
| Jun 30, 2019 | 69.14% |
| Mar 31, 2019 | 77.75% |
| Dec 31, 2018 | 77.86% |
| Sep 30, 2018 | 93.39% |
| Jun 30, 2018 | 111.06% |
| Mar 31, 2018 | 115.51% |
| Dec 31, 2017 | 141.69% |
| Sep 30, 2017 | 125.43% |